Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
NCT ID: NCT06124131
Last Updated: 2025-05-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2023-11-11
2024-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Do patient financial incentives for completing colorectal cancer screening increase screening completion?
* Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?
Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment.
Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Center Randomized Pilot Study Of Colorectal Cancer Screening Outreach
NCT02594150
Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening
NCT05693649
Educational Program to Increase Colorectal Cancer Screening: a Cluster Trial
NCT01805622
Testing Interventions to Motivate and Educate
NCT01568151
Tailored Messaging for CRC Screening
NCT03310892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Full financial incentives
$50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening
Financial incentive for colorectal cancer screening
$50 incentive paid to participant for completion of colorectal cancer screening within 2 months of enrollment
Financial incentive for flu shot
$50 incentive paid to participant for completion of flu shot within 2 months of enrollment
Financial incentive for COVID-19 shot
$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment
Partial financial incentives
$50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Financial incentive for flu shot
$50 incentive paid to participant for completion of flu shot within 2 months of enrollment
Financial incentive for COVID-19 shot
$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Financial incentive for colorectal cancer screening
$50 incentive paid to participant for completion of colorectal cancer screening within 2 months of enrollment
Financial incentive for flu shot
$50 incentive paid to participant for completion of flu shot within 2 months of enrollment
Financial incentive for COVID-19 shot
$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receive care at participating primary care clinic
* Due for colorectal cancer screening
* Ability to understand and speak English
Exclusion Criteria
* Unable or unwilling to give informed consent
45 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Tulane University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie A Krousel-Wood, MD, MSPH
Role: PRINCIPAL_INVESTIGATOR
Tulane University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tulane University School of Medicine
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-1600-BENC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.